Merck Rewards Pioneering Researchers
Grant for Oncology Innovation Initiative grants €1 Mio
29-Sep-2015
- Germany
Merck announced the winners of the 2015 Grant for Oncology Innovation (GOI), who will receive grants totaling €1 million.This year’s winners are:
- Dr Roberto Chiarle, University of Turin, Italy, for his proposal to elucidate the molecular mechanisms underlying relapse in a subset of patients with non-small cell lung cancer, following anaplastic lymphoma kinase (ALK)-targeted tyrosinekinase inhibitor (TKI) therapy. Around half of patients treated with ALK-TKI therapy will relapse without explanation, meaning they are not able to benefit from additional lines of targeted therapy.
- Dr Josep Maria Piulats Rodriguez, Catalan Institute of Oncology, Spain, for his proposal to explore immunogenic mutations as a therapeutic target, and to demonstrate the potential for personalized cancer-specific vaccines to generate T-cell responses in human tumors.
- Dr Rodrigo Dienstmann, Vall d'Hebron Institute of Oncology, Spain, for his proposal to analyze clinical and gene expression data, and translating the findings to inform the design of early clinical trials into therapies that target intracellular signals on which colorectal cancers depend.
Other news from the department science
